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Abstract
Objective: The aim of this study was to evaluate the reporting of relevant prognostic information in a sample of randomized
controlled trials (RCTs) that investigated treatments for patients with chronic low back pain (LBP). We also analysed how
researchers conducting the meta-analyses and systematic reviews addressed the reporting of relevant prognostic
information in RCTs.
Methods: We searched the Cochrane Database to identify systematic reviews that investigated non-surgical treatments for
patients with chronic LBP. The reported prognostic information was then extracted from the RCTs included in the reviews.
We used a purpose-defined score to assess the quantity of information reported in the RCTs. We also determined how the
authors of systematic reviews addressed the question of comparability of patient populations between RCTs.
Results: Six systematic reviews met our inclusion criteria, and we analysed 84 RCTs. Based on the scores, the reporting of
important prognostic variables was incomplete in almost half of the 84 RCTs. Information regarding patients’ general health,
social support, and work-related conditions was rarely reported. Almost half of the studies included in one of the meta-
analyses provided insufficient information that did not allow us to determine whether patients in the primary trials were
comparable.
Conclusions: Missing prognostic information potentially threatens the external validity (i.e. the generalizability or
applicability) not only of primary studies but also of systematic reviews that investigate treatments for LBP. A detailed
description of baseline patient characteristics that includes prognostic information is needed in all RCTs to ensure that
clinicians can determine the applicability of the study or review results to their patients.
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Introduction
Assessing the external validity of randomized controlled trials
(RCTs) is a key step in the critical appraisal of clinical studies.
Many clinicians trust authors and journal editors to verify the high
internal validity of the published studies (e.g., concealment of
randomization list, information about drop-outs, intention to treat
analysis), but physicians must decide for themselves whether the
results apply to an individual patient. The information that is
needed for this determination is reported in the Methods and
Results sections of journal articles. The Methods section reports
the eligibility criteria information, which states the patient
qualifications for inclusion in the study. Patient characteristics
are reported in the Results section; quite often, the article’s Table 1
shows the distribution of characteristics of patients included in the
study. Guidelines for reporting, e.g., the CONSORT Statement
for randomized controlled trials [1], recommend not only a
comprehensive description of eligibility criteria but also a list of
baseline characteristics for important prognostic factors.
A complete description of relevant prognostic factors is
particularly important in otherwise ill-defined diseases, such as
chronic low back pain (CLBP). Several prognostic factors have
been identified that can affect treatment effects in patients with
CLBP, including age, duration of symptoms, first or recurrent
episode, employment status, and comorbidities such as depression
[2,3]. For example, a treatment is effective in patients without
depression but be less effective or even ineffective in depressed
patients [4].
Knowing the patients’ baseline characteristics is important for
interpreting study results, both for clinicians and for the
researchers who conduct systematic reviews and meta-analyses.
Pooling the results of primary studies with unknown or different
distributions of relevant prognostic factors in the included
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population may lead to a biased result [5]. It is unclear whether
authors report important prognostic information in sufficient detail
in primary studies so as to be helpful in rational pooling of data in
meta-analyses and systematic reviews.
The aim of the current study was to evaluate the reporting of
relevant prognostic information in a selection of randomized
controlled trials (RCTs) investigating treatment outcomes in
patients with CLBP. We also determined whether the authors of
systematic reviews addressed the question of comparability of
patient populations between RCTs.
Methods
Study Design
Here we analysed primary studies included in CLBP-related
systematic reviews in the Cochrane library. For the purpose of the
current study, CLBP represents an ill-defined disease with high
health care expenditure [6] for which important prognostic
information is known to influence the course of the disease [3,7].
We aimed to include a complete set of trials for each treatment
intervention; therefore, we analysed primary studies that were
included in systematic reviews published in the Cochrane library.
The Cochrane Collaboration Guideline [8,9,10] has published
guidelines for the standardized assessment of baseline character-
istics to facilitate comparison of systematic reviews. While this
study is not a systematic review reporting will be based, if
applicable, on the recommendations of the PRISMA statement
[11].
Eligibility Criteria and Selection of Systematic Reviews
All systematic reviews that were published in the Cochrane
library from its inception (1996) to December 2010 that
investigated non-surgical treatments for CLBP were eligible for
inclusion in our analysis. We searched the Cochrane library for the
terms ‘‘chronic’’ and ‘‘non-specific low back pain’’ in the title,
abstract, or keywords. Of the returned reviews, only RCTs
published in English and German were eligible for further analysis
due to the authors’ lack of proficiency in other languages. Non-
randomized trials and observational studies were excluded.
Two reviewers (MW and MS) independently screened the titles
and abstracts of the identified systematic reviews to determine
which ones met the pre-defined inclusion criteria. The full text of
each RCT included in the systematic reviews were then
independently reviewed (MW and MS). Discrepancies between
the two reviewers were discussed and resolved by consensus or by
a third party (FB).
Data Extraction and Synthesis
One reviewer (MS) extracted data from the RCTs, including
bibliographic data (authors, year of publication), eligibility criteria,
and prognostic information. Prognostic information for LBP was
defined a priori in collaboration with experienced clinicians (one
internist, one rheumatologist, one general practitioner) and one
methodologist in the field and by consulting the relevant literature
[2,3].
We used the prognostic domains proposed by Hayden et al. [7]
to categorize the information reported in the RCTs. These
domains, which are considered to represent clinically meaningful
groups, [2] have been used in previous research and are based on
expert consensus [12]. The following six main domains were used:
general patient characteristics, baseline health status, work-related
factors, current low back pain (LBP), clinical examination findings,
and interactions with work/society. Each main domain is divided
into subdomains (e.g., current LBP is further divided according to
the patient’s clinical history, disability related to the complaint,
and changes in the complaint over time). There were a total of 16
prognostic subdomains (Table 1). The six main domains represent
a spectrum of important information that helps clinicians decide
whether the study results are applicable to their patients.
One reviewer (MW) confirmed all of the extracted information
and assigned the data to the appropriate subdomains. To quantify
the amount of reported prognostic information for each RCT, we
defined a Score for the Quantity of Reporting (SQR) for each one
as follows: High SQR, information was reported for one or more
subdomain in all six main domains; moderate SQR, information
was reported for one or more subdomains in five of the six main
domains; and low SQR, information was reported for one or more
subdomains in four or fewer main domains (Table 1).
The SQR for each study was then compared to how the
baseline characteristics were assessed in the systematic reviews.
Assessment of the comparability of baseline characteristics in
studies is defined in the Method guidelines for systematic reviews
in the Cochrane Collaboration Back Review Group for Spinal
Disorders [8] (first published in 1997). The relevant question is:
‘‘Are the baseline characteristics similar with regards to the most
important prognostic factors?’’ The possible answers are ‘‘Yes/
Table 1. Important prognostic risk factor domains and subdomains in patients with low back pain (modified from Hayden et al.
[7]).
Domain Subdomain SQR Score*
General patient characteristics Socio-demographic status Social support Minimal requirement: $1 subdomain reported
Baseline health status Overall health Overall psychological health Previous LBP Minimal requirement: $1 subdomain reported
Work-related factors Work: psychosocial demands Work: physical demands Work
history Work place attributes
Minimal requirement: $1 subdomain reported
Current LBP Clinical history Disability related to the complaint Changes
related to complaint over time
Minimal requirement: $1 subdomain reported
Clinical examination findings Physical examination findings Definition of NSLBP diagnosis{
Changes found during the physical exam
Minimal requirement: $1 subdomain reported
Interactions with work/society Compensation issues related to LBP Minimal requirement: $1 subdomain reported
LBP: low back pain; NSLBP: nonspecific low back pain;
{To fulfil this subdomain, at least one more attribute (in addition to pain duration) had to be reported (e.g. disability, severity, pain referral) [30];
*SQR: Score for the quantity of reporting: Scoring SQR high: information reported in one or more subdomains for all six main domains; SQR moderate: information
reported in one or more subdomains for five main domains; SQR low: information reported in one or more subdomains for four or fewer main domains.
doi:10.1371/journal.pone.0058512.t001
Prognostic Information Influence External Validity
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No/Don’t know,’’ and studies were divided into ‘‘Yes’’, ‘‘No’’, or
‘‘Can’t tell’’ categories depending on the answer to that question.
The updated Method Guidelines in 2003 [9] further stated, ‘‘In
order to qualify for a ‘‘Yes,’’ groups have to be similar at baseline
regarding demographic factors, duration and severity of com-
plaints, percentage of patients with neurologic symptoms.’’ When
not enough information is reported, the study must be classified as
‘‘Can’t tell’’. We would expect that for primary studies with low
SQRs, the answer to the above question would be ‘‘Can’t tell.’’ We
also investigated whether studies with low SQR or that were
classified as ‘‘Can’t tell’’ were included in the meta-analysis.
Statistical Analysis
Descriptive statistics were used to summarize findings across the
entire set of RCTs. We wished to evaluate changes in the quantity
of reporting over time, particularly after the publication of the
CONSORT statement in 1996 [1], which aimed to improve the
quality of reporting in RCTs. Toward this end, the mean number
of reported subdomains before and after 1998 (to allow one year
for implementation of CONSORT suggestions) was compared
using the t-test. Analyses were conducted with SPSS for Windows
version 19 (IBM SPSS; Chicago, IL USA) and R statistical
software for Windows (http://www.R-project.org/).
Figure 1. Study flow chart. The Cochrane Database of Systematic Reviews was searched in November, 2010.
doi:10.1371/journal.pone.0058512.g001
Prognostic Information Influence External Validity
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Ethics Statement
For this study no ethical approval was required. No protocol
was published or registered. All methods were determined a priori.
Results
Study Selection
Seven systematic reviews met the eligibility criteria (Figure 1).
The reviews were published between 2005 and 2010 and included
100 primary studies. A total of 84 primary studies (RCTs) were
included in the analysis. The main reason for exclusion was
publication in a language other than English (n = 16). Figure 1
shows a flow diagram of the study selection process.
Study Characteristics
Table 2 summarizes the objectives, the number of included
RCTs, and the conclusions of each systematic review. Most RCTs
aimed to investigate treatments only for chronic low back pain; few
studies included patients with subacute and acute low back pain.
The number of RCTs included in each systematic review ranged
from four [13] to thirty-two [14] trials. The RCTs were published
between 1971 and 2009. More than half of the studies assessed the
effects of acupuncture (n = 18, 21.4%) or cognitive behavioural
therapy (n= 27, 32.1%). Most patients in the control groups
received placebo (n= 26, 30%), sham procedures (n = 12, 14%), or
usual care (n = 12, 14%), or the patients were placed on a waiting
list (n = 13, 15%). In most studies, the follow-up time was about 6
months (median 6 months, range 1 hour to 5 years). Details are
shown in Table 3.
Reporting of Important Prognostic Factors in Primary
Studies
The information reported for the domains and subdomains is
summarized in Table 4. The data reported most often were data
about socio-demographic status and the history of the current
LBP. Information about the patient’s general health status, social
support, and work-related information was rarely reported.
Although statistically significant (p-value = 0.01), the mean num-
ber of subdomains with reported information increased after 1998
by fewer than two subdomains (from a mean of 5.4 subdomains to
7.0 subdomains). In studies published after 2001, the median
number of subdomains with reported information increased to 8
(of a possible total of 16 subdomains), reflecting a trend towards
improved reporting of prognostic important information in recent
years (Figure 2).
In 17 of the 84 studies (20%), information was reported for all
six of the main domains (high SQR). Information was reported for
five of the six main domains (moderate SQR) in 30 studies (36%)
and for four or fewer domains (low SQR) in 37 studies (44%). The
27 studies investigating cognitive behavioural or educational
therapy (termed CBT) provided information for more domains
on average (high or moderate SQR for 82%) than studies of other
Table 2. Summaries of the systematic reviews in our analysis.
Author Year Objective
Number of
studies
analysed Conclusion
Furlan et al. [32] 2005 To assess the effects of AC for the
treatment of NSLBP and the effects
of dry-needling for myofascial pain
syndrome in the low-back region.
20 Acute LBP: no firm conclusions about the effectiveness of AC. Chronic
LBP: AC more effective for pain relief and functional improvement
than no treatment or sham treatment and in the short-term only. AC is
not more effective than other conventional treatments.
Urquhart et al. [33] 2008 To determine whether antidepressants
are more effective than placebo for
the treatment of NSLBP
9 No clear evidence that antidepressants are more effective than
placebo in the management of patients with CLBP.
Henschke et al. [14] 2010 To determine the effects of behavioural
therapy for CLBP and the most effective
behavioural approach
32 Short-term: moderate quality evidence that operant therapy is more
effective than being placed on a waiting list and that behavioural
therapy is more effective than usual care for pain relief. No specific
type of behavioural therapy is more effective than another.
Intermediate- to long-term: Little or no difference between
behavioural therapy and group exercises for pain or depressive
symptoms.
Staal et al. [34] 2008 To determine if injection therapy is more
effective than placebo or other treatments
for patients with subacute or chronic LBP.
10 Insufficient evidence to support the use of injection therapy in
subacute and chronic LBP. Insufficient data to answer whether specific
subgroups of patients respond to a specific type of injection therapy.
Deshpande et al. [35] 2007 To determine the efficacy of opioids in
adults with CLBP.
4 Quality remark: Although high internal validity scores, the study
showed a lack of generalizability, inadequate description of study
populations, a poor intention-to-treat analysis, and limited
interpretation of functional improvement. The benefits of opioids in
clinical practice for the long-term management of CLBP remain
questionable.
Dagenais et al. [36] 2007 To determine the efficacy of
prolotherapy in adults with CLBP.
5 When used alone, prolotherapy is not an effective treatment for CLBP.
When combined with spinal manipulation, exercise, and other co-
interventions, prolotherapy may improve CLBP and disability. Quality
remark: Conclusions are confounded by clinical heterogeneity
amongst studies and by the presence of co-interventions.
Khadilkar et al. [37] 2008 To determine whether TENS is more
effective than placebo for the
management of CLBP.
4 The current evidence from a small number of placebo-controlled trials
does not support the use of TENS in the routine management of CLBP.
CLBP/NSLBP: chronic low back pain/nonspecific low back pain; LBP: low back pain; AC: acupuncture; UC: usual care; TENS: transcutaneous electrical nerve stimulation.
doi:10.1371/journal.pone.0058512.t002
Prognostic Information Influence External Validity
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interventions. There was poor reporting in the main domains in
studies investigating acupuncture, injection therapy, antidepres-
sants, and opioids (SQR poor in 72–100% of the RCTs) (Table 5).
Figure 2. Boxplot showing the number of reported subdomains per primary study over time before and after publication of the
CONSORT statement (1996).
doi:10.1371/journal.pone.0058512.g002
Table 4. Quantity of information in the prognostic
subdomains in the 84 RCTs.
Domain Subdomain Total %
General patient
characteristics
Sociodemographic information 80 95
Social support 8 10
Baseline health status Overall health 22 26
Overall psychological health 47 56
Previous LBP 33 39
Work-related factors Work: psychosocial demands 1 1
Work: physical demands 6 7
Work history 39 46
Work place attributes 3 4
Current LBP Clinical history 67 80
Disability related to the complaint 48 57
Changes related to complaint over time38 46
Clinical examination
findings
Physical examination findings 25 30
Definition of NSLBP diagnosis 56 67
Change found during the physical
exam
21 25
Interactions with
work/society
Compensation issues related to LBP 36 43
LBP: low back pain; NSLBP: non-specific low back pain.
doi:10.1371/journal.pone.0058512.t004
Table 5. Summary of the Score for Quantity of reporting
(SQR) types for the RCTs.
SQR high SQR moderate SQR low
All studies (n = 84, 100%) 17 (20%) 30 (36%) 37 (44%)
Acupuncture (n = 18, 21%) 0 (0%) 5 (28%) 13 (72%)
Antidepressants (n = 9, 11%) 1 (5.5%) 1 (5.5%) 8 (89%)
Opioids (n = 4, 5%) 0 (0%) 0 (0%) 4 (100%)
CBT (n = 27, 32%) 11 (41%) 11 (41%) 5 (18%)
TENS: (n = 5, 6%) 1 (20%) 1 (20%) 3 (60%)
EMG (n = 4, 5%) 0 (0%) 2 (50%) 2 (50%)
Reflexology (n = 1, 1%) 0 (0%) 1 (100%) 0 (0%)
Injection Therapy (n = 11,
13%)
2 (18%) 0 (0%) 9 (82%)
Prolotherapy (n = 5, 6%) 2 (40%) 0 (0%) 3 (60%)
CBT: cognitive behavioural therapy or educational therapy; TENS:
transcutaneous electrical nerve stimulation; EMG: electromyography;
Prolotherapy: Repeated injections of irritant solutions to strengthen
lumbosacral ligaments; SQR: Score for quantity of reporting, scoring SQR high:
information reported in one or more subdomains for all six main domains; SQR
moderate: information reported in one or more subdomains for five main
domains; SQR low: information reported in one or more subdomains for four or
fewer main domains.
doi:10.1371/journal.pone.0058512.t005
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Comparison of the Classification Systems for Reporting
Prognostic Factors Using SQR and the Cochrane
Collaboration Guidelines for Baseline Characteristics
(CCG-baseline)
In the systematic reviews, the reporting of baseline character-
istics was classified as ‘‘Can’t tell’’ in 17 of the 84 studies (20%).
The CCG-baseline rating was ‘‘Similar’’ for 59 studies and ‘‘Not
similar’’ for 8 studies, indicating that sufficient information for
classification was available in most of the studies. The baseline
characteristics were classified by the reviewers either as ‘‘Similar’’
or ‘‘Not similar’’ in almost two thirds of the studies with low SQRs
(34 studies, 40%) (Table 6). There was thus moderate agreement
between the two rating systems, i.e. SQR and CCG-baseline.
Of the 44 studies pooled for meta-analysis, the SQR was low in
22 studies (50%), and 8 (18%) of the studies were classified as
‘‘Can’t tell’’ according to the CGC-baseline system (Table 7). Five
(11%) of the 44 pooled studies were classified as low SQR and
‘‘Can’t tell’’ according to the CGC-baseline system.
Discussion
Main Findings
In a selection of RCTs that examined various treatments for
LBP, there was sparse reporting of relevant baseline characteristics
and of prognostic information in particular. This information is
needed by clinicians who wish to extrapolate the results to
individual patients and by those who conduct meta-analyses who
must decide whether it makes sense to pool the results of different
studies. The reporting of important prognostic variables could
have been more complete in almost half of the assessed trial
reports. Even information that could be obtained without great
effort and expense, e.g., information on general health status,
social support, and work-related conditions, was rarely reported.
Half of the studies included in one of the meta-analyses failed to
provide enough information for the reader to make an informed
decision about whether patients in the primary trials were
comparable.
Comparison with Other Studies
To our knowledge, this is the first study to focus on the reporting
of baseline characteristics in RCTs of patients with chronic LBP
and to focus on how this issue is addressed in systematic reviews.
Baseline patient characteristics are mainly prognostic factors. A
comprehensive description of the distribution of these prognostic
factors is relevant for determining the applicability of the study
results to various patient populations. Comparable analyses have
been performed for systematic reviews of prognostic cohort studies
[2,15] and non-randomized intervention studies [16]. The authors
of those studies identified incomplete reporting of prognostic
factors and recommended a more detailed description of the
included patients. Regardless of study design, an incomplete
description of patient characteristics increases the risk for bias in
interpreting the results of single studies and systematic reviews. A
detailed description of the study population helps researchers
decide whether it makes sense to pool results from different studies
and helps them perform subgroup analyses. The guidelines for
conducting systematic reviews mention, without providing detailed
instructions, evaluating the comparability of patient populations
between primary studies [10,17,18,19]. We found no studies that
evaluated the consequences of incomplete reporting of baseline
characteristics on the ability of physicians and researchers to
interpret RCTs, systematic reviews and meta-analyses.
Clinical Implications
Many current guideline recommendations are based on the
results of systematic reviews and meta-analyses, which are ranked
highest in the hierarchy of evidence [20]. A thorough and careful
synthesis of primary studies is crucial to warrant this ranking.
Critique has been raised on the appraisal of systematic reviews and
consequentially on the justification of recommendations in the
guidelines. There is a controversy for example about the
differences in the rating of the methodological quality of systematic
reviews [21]. Another issue of concern physicians repeatedly bring
up in educational meetings is the inclusion of RCTs in systematic
reviews with conflicting or even contradictory results. Physicians
question the comparability of patient populations included in
systematic reviews and meta-analyses. Conflicting results in RCTs
Table 6. Comparison of the Score for Quantity of Reporting (SQR) categories (high/moderate/low) for the 84 RCTs and the
Cochrane Collaboration Guideline-baseline characteristics (CCG-baseline) categories (Similar/Not similar/Can’t tell).
All RCTs (n=84, 100%) CCG-baseline: Similar or Not similar (n=67, 80%) CCG-baseline: ‘‘Can’t tell’’ (n =17, 20%)
SQR high (n = 17, 20%) 17 (20%) 0 (0%)
SQR moderate (n = 20, 24%) 16 (19%) 4 (5%)
SQR low (n = 47, 56%) 34 (40%) 13 (15%)
doi:10.1371/journal.pone.0058512.t006
Table 7. Comparison of the Score for Quantity of Reporting (SQR) categories (high/moderate/low) for the 44 RCTs included in
meta-analyses and the Cochrane Collaboration Guideline-baseline characteristics (CCG-baseline) categories (Similar/Not similar/
Can’t tell).
All RCTs (n=44, 100%) CCG-baseline: Similar or Not similar (n =36, 81%) CCG-baseline ‘‘Can’t tell’’ (n = 8, 19%)
SQR high (n = 11, 25%) 9 (20%) 2 (5%)
SQR moderate (n = 11, 25%) 10 (23%) 1 (2%)
SQR low (n = 22, 50%) 17 (39%) 5 (11%)
doi:10.1371/journal.pone.0058512.t007
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could reflect a heterogeneous patient population with a range of
prognostic profiles [22]. Other explanations for heterogeneity in
the results between primary studies on LBP might be, e.g., varying
drug dosages or different numbers of training units in exercise
therapy, differences in the measurement of the outcome, and
outcome measurement at different time points.
While the problem of heterogeneity has been recognized, there
is not much research on this issue in conservative treatment for low
back pain [23]. However, in clinical practice it is important to
know to which degree patient characteristics at baseline affects
treatment efficacy. From a clinician’s perspective it seems
reasonable to assume that certain treatments (e.g., cognitive
behavioral therapy) are more effective in patients presenting with
yellow flags (e.g., fear avoidance beliefs, distress) or depression. It is
therefore relevant to know about specific treatment effects in
subgroups of patients. Clinicians expect from researchers that this
heterogeneity in treatment effects is scrutinized and relevant
prognostic patient characteristics are considered in the synthesis of
RCTs in order to offer an evidence-based and goal oriented health
care to the patients [24].
Various concerns on the value of systematic reviews and meta-
analyses have been raised in the past years that are beyond the
scope of this analysis [20,25,26,27,28]. Systematic reviews offer the
possibility to exploit the heterogeneity of prognostic profiles and to
conduct subgroup analyses. Thus, reporting the relevant baseline
characteristics in primary studies is critical for the quality of the
systematic review. Further, collaboration between clinicians and
methodologists allows for a meaningful pooling of data in meta-
analyses and to examine treatment effects in different groups of
patients with LBP. A striking example that underlines the
importance of clinical knowledge and subgroup analyses is a
recent systematic review investigating vitamin D supplementation
for the protection of hip fracture [29]. While the overall effect in
this systematic review including all patients, irrespective of their
vitamin D blood level at baseline, was not different to placebo,
vitamin D protected against hip fractures in individuals with low
vitamin D levels at the time of inclusion in the trials.
Limitations of the Study
While we applied robust methodology and a systematic
approach to assess the reporting of prognostic information in
RCTs, the current study has some limitations. In using a score
based on domains, all prognostic information was given equal
weight. We are aware that this may be an over-simplification. The
cut-off for ‘low SQR’ used in the current study was chosen
arbitrarily, and more studies would have fulfilled the quality
criteria if the cut-off was lower. Because we accepted that any
reported information was sufficient to fulfil a domain, we think the
cut-off we used was reasonable. Accordingly, non-reporting of
information in two or more main domains represents a risk for
misinterpretation of results not only in primary studies but also in
systematic reviews. We support current efforts to standardize
measurements of prognostic factors and reporting in back pain
research that will make it easier to compare studies in the future
[3,30].
Another limitation of our study is the focus was only on RCTs
that were included in systematic reviews published in the
Cochrane library. Inclusion of RCTs in systematic reviews
published in other databases might give different results. We
chose the Cochrane systematic reviews as they are widely
recognized as setting the standard for the evaluation of healthcare
interventions [31]. Furthermore, the standardized risk of bias
assessment in all systematic reviews ensures similar assessment in
the different reviews. While the Cochrane reviews are relatively
recent, the most recent trial included in our analysis was published
in 2009, and more important prognostic information might be
reported in more recent studies. Our analysis of changes in
reporting over time showed a small but statistically significant
increase in reporting in the ten years after publication of the
CONSORT statements.
Conclusion
Missing prognostic information potentially threatens the exter-
nal validity (i.e. generalizability or applicability) not only of
primary studies but also of systematic reviews that evaluate
treatments for LBP. A detailed description of baseline character-
istics, including important prognostic information, will help
clinicians and researchers make informed decisions about whether
the results of a study or a systematic review apply to their patients.
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